Results 61 to 70 of about 8,311 (216)

IgM Myeloma or Waldenstrom\u27s Macroglobulinemia Is the Big Question? [PDF]

open access: yes, 2014
: Although critical from therapeutic and prognostic perspectives, differentiating IgM Myeloma (MM) from Waldenstrom\u27s macroglobulinemia (WM) is fraught with failure.
Pant, S.   +5 more
core   +1 more source

DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis

open access: yesHematological Oncology, Volume 44, Issue 5, September 2026.
ABSTRACT BCL6 is a master transcriptional regulator of germinal center (GC) B cells. BCL6 is frequently translocated at the major translocation cluster (MTC) within intron 1 of the BCL6 locus, a hotspot commonly rearranged in diffuse large B cell lymphomas (DLBCLs).
Santosh Kumar Gothwal   +4 more
wiley   +1 more source

Zanubrutinib Combined With Rituximab in the Treatment of Bing‐Neel Syndrome: A Case Report

open access: yesClinical Case Reports
Bing‐Neel syndrome (BNS) is a rare complication of Waldenström macroglobulinemia, a condition with low incidence in clinical practice and prone to misdiagnosis.
Rongyao Zhang   +4 more
doaj   +1 more source

Optimization of Reflex Testing Rules on the Sysmex XN‐9100 Automated Hematology Line Improves Efficiency and Reduces Repeat Testing in Different Work Areas

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 18, September 2026.
This graphical abstract summarizes a workflow‐based Reflex rule optimization for the Sysmex XN‐9100 automated hematology line. A total of 78,364 routine complete blood count samples were analyzed by middleware simulation. The optimized strategy differentiated initial from follow‐up visit samples, incorporated 7‐day historical fluctuation thresholds ...
Lianhui Yu   +5 more
wiley   +1 more source

Waldenström Macroglobulinemia Mimicking A Primary Lung Carcinoma [PDF]

open access: yes
Waldenström macroglobulinemia (WM) is a rare hematological disease that accounts for 1-2% of non-Hodgkin lymphomas. WM is a variant of lymphoplasmocytic lymphoma and is characterized by bone marrow involvement as well as immunoglobulin M monoclonal ...
Nalan Akyürek   +6 more
core   +1 more source

Nucleic acid biomarkers in Waldenstrom Macroglobulinemia and IgM-MGUS : current insights and clinical relevance

open access: yes, 2022
Waldenstrom Macroglobulinemia (WM) is an indolent lymphoplasmacytic lymphoma, characterized by the production of excess immunoglobulin M monoclonal protein.
Vandesompele, Jo   +14 more
core   +1 more source

IMMUNOCHEMICAL STUDIES IN A PATIENT WITH WALDEN-STROM'S MACROGLOBULINEMIA [PDF]

open access: yesActa Medica Iranica, 1978
Waldenstrom's macroglobulinemia was studied in a 46 year old Iranian male with anemia, bleeding, ecchymose and splenomegaly. The diagnosis of Macroglobulinemia was established by the presence of veryhigh level of IgM paraprotein in sera which was ...
M. Mir-Ahmadian   +3 more
doaj  

Management and long‐term haematological and neurological outcomes of Immunoglobulin M and Waldenström's macroglobulinaemia‐related neuropathy: A single‐centre experience

open access: yesBritish Journal of Haematology, Volume 209, Issue 3, Page 1031-1038, September 2026.
In this 28‐patient retrospective cohort, rituximab‐based regimens for IgM‐related neuropathy yielded significant, sustained functional and neurological improvements over a 2‐year follow‐up. Furthermore, reductions in serum IgM levels correlated with improved Inflammatory Neuropathy Cause and Treatment disability scores, highlighting the long‐term ...
Maria Gavriatopoulou   +15 more
wiley   +1 more source

The bone marrow microenvironment in Waldenstrom macroglobulinemia

open access: yes, 2011
Waldenstrom macroglobulinemia (WM) is a low-grade B-cell lymphoproliferative disorder characterized primarily by specific homing and growth of tumor cells within the bone marrow niches.
Ghayas Issa   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy